Page 6 - Read Online
P. 6

18         Ablative techniques in hepatocellular carcinoma treatment
                            Ehsun Naeem, Shahab Abid
                            Hepatoma Res 2018;4:18  http://dx.doi.org/10.20517/2394-5079.2018.22


               19         Mitoepigenetics and hepatocellular carcinoma
                            María Guadalupe Lozano-Rosas, Enrique Chávez, Alejandro Rusbel Aparicio-Cadena, Gabriela
                            Velasco-Loyden, Victoria Chagoya de Sánchez
                            Hepatoma Res 2018;4:19  http://dx.doi.org/10.20517/2394-5079.2018.48

               20         Intrahepatic cholangiocarcinoma: review and update
                            Vincenzo Cardinale, Maria Consiglia Bragazzi, Guido Carpino, Sabina Di Matteo, Diletta Overi,
                            Lorenzo Nevi, Eugenio Gaudio, Domenico Alvaro
                            Hepatoma Res 2018;4:20  http://dx.doi.org/10.20517/2394-5079.2018.46

               21         Pathway analysis provides insight into the genetic susceptibility to hepatocellular carcinoma and
                            insight into immuno-therapy treatment response
                            Yih-Kuang Lu, Jacob Morris Brill, Ardesher Aghili, Kenneth Howard Buetow
                            Hepatoma Res 2018;4:21  http://dx.doi.org/10.20517/2394-5079.2018.44

               22         Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in
                            this challenging tumor
                            Gabriele Missale, Elisabetta Cariani
                            Hepatoma Res 2018;4:22  http://dx.doi.org/10.20517/2394-5079.2018.72


               23         Molecular targeting of antiviral drugs used against hepatitis C virus infection
                            Mohammad Irshad, Priyanka Gupta, Khushboo Irshad
                            Hepatoma Res 2018;4:23  http://dx.doi.org/10.20517/2394-5079.2018.25


               24         Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean
                            countries
                            Suna Yapali, Nurdan Tozun
                            Hepatoma Res 2018;4:24  http://dx.doi.org/10.20517/2394-5079.2018.57

               25         HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular
                            carcinoma: still an issue?
                            Francesco Paolo Russo, Martina Tessari, Angela Imondi, Erica Nicola Lynch, Fabio Farinati
                            Hepatoma Res 2018;4:25  http://dx.doi.org/10.20517/2394-5079.2018.52

               26         Hypoxic microenvironment and hepatocellular carcinoma treatment
                            Ci-Ai Lin, Lin-Lin Chang, Hong Zhu, Qiao-Jun He, Bo Yang
                            Hepatoma Res 2018;4:26  http://dx.doi.org/10.20517/2394-5079.2018.27


               27         Expression quantitative trait loci for PVT1 contributes to the prognosis of hepatocellular
                            carcinoma
                            Ting Tian, Ci Song, Zhe-Ning Pu, Zi-Jun Ge, Cheng-Xiao Yu, Ji-Bin Liu, Zhi-Bin Hu
                            Hepatoma Res 2018;4:27  http://dx.doi.org/10.20517/2394-5079.2018.24
   1   2   3   4   5   6   7   8   9   10   11